Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6105)
All Articles published online
|
Publishing Process of This Article
|
Sep 16, 2013 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yokoyama Y, Mizunuma H. Recurrent epithelial ovarian cancer and hormone therapy. World J Clin Cases 2013; 1(6): 187-190 [PMID: 24303498 DOI: 10.12998/wjcc.v1.i6.187] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v1/i6/187.htm |
| Number | Citing Articles |
| 1 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 317 doi: 10.1002/9783527838561.ch14
|
| 2 |
Rajmohan Murali, Rachel N. Grisham, Robert A. Soslow. The roles of pathology in targeted therapy of women with gynecologic cancers. Gynecologic Oncology 2018; 148(1): 213 doi: 10.1016/j.ygyno.2017.11.020
|
| 3 |
Elizabeth Lokich, Rakesh K. Singh, Alex Han, Nicole Romano, Naohiro Yano, Kyukwang Kim, Richard G. Moore. HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation. Scientific Reports 2014; 4(1) doi: 10.1038/srep05500
|
| 4 |
Wei-Min Chung, Lumin Chen, Wei-Chun Chang, Sheng-Yuan Su, Yao-Ching Hung, Wen-Lung Ma. Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials. International Journal of Molecular Sciences 2021; 22(14): 7748 doi: 10.3390/ijms22147748
|
| 5 |
Bryan Oronsky, Carolyn M. Ray, Alexander I. Spira, Jane B. Trepel, Corey A. Carter, Hope M. Cottrill. A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer. Medical Oncology 2017; 34(6) doi: 10.1007/s12032-017-0960-z
|
| 6 |
Luiz Gustavo de Almeida Chuffa, Luiz Antonio Lupi-Júnior, Aline Balandis Costa, João Paulo de Arruda Amorim, Fábio Rodrigues Ferreira Seiva. The role of sex hormones and steroid receptors on female reproductive cancers. Steroids 2017; 118: 93 doi: 10.1016/j.steroids.2016.12.011
|
| 7 |
Hsin‐Ling Yang, Ruei‐Wan Lin, Peramaiyan Rajendran, Dony Chacko Mathew, Varadharajan Thigarajan, Chuan‐Chen Lee, Chih‐Jung Hsu, You‐Cheng Hseu. Antrodia salmonea‐induced oxidative stress abrogates HER‐2 signaling cascade and enhanced apoptosis in ovarian carcinoma cells. Journal of Cellular Physiology 2019; 234(3): 3029 doi: 10.1002/jcp.27123
|
| 8 |
Ioannis A. Voutsadakis. Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations. Clinical Medicine Insights: Oncology 2016; 10 doi: 10.4137/CMO.S32813
|
| 9 |
Carlota Claussen, Lars Hanker. Aktuelles zur systemischen Rezidivtherapie des epithelialen Ovarialkarzinoms. Der Gynäkologe 2022; 55(3): 176 doi: 10.1007/s00129-022-04904-x
|
| 10 |
Lev M. Berstein. Resistance to Aromatase Inhibitors in Breast Cancer. Resistance to Targeted Anti-Cancer Therapeutics 2015; 8: 261 doi: 10.1007/978-3-319-17972-8_12
|
| 11 |
Susanne Schüler-Toprak, Christoph Moehle, Maciej Skrzypczak, Olaf Ortmann, Oliver Treeck. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3246-0
|
| 12 |
Edward J. Filardo. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis. The Journal of Steroid Biochemistry and Molecular Biology 2018; 176: 38 doi: 10.1016/j.jsbmb.2017.05.005
|
| 13 |
Carlota Claussen, Achim Rody, Lars Hanker. Treatment of Recurrent Epithelial Ovarian Cancer. Geburtshilfe und Frauenheilkunde 2020; 80(12): 1195 doi: 10.1055/a-1128-0280
|
| 14 |
Felicitas Mungenast, Theresia Thalhammer. Estrogen Biosynthesis and Action in Ovarian Cancer. Frontiers in Endocrinology 2014; 5 doi: 10.3389/fendo.2014.00192
|
| 15 |
Shouzhen Chen, Xujing Dai, Yifei Gao, Fang Shen, Jingxin Ding, Qi Chen. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17265-6
|
| 16 |
Jerome Lorenzini, Marion Deberti, Gilles Body, Xavier Carcopino, Cyril Touboul, Yohann Dabi, Pierre Collinet, Charles Coutant, Cherif Akladios, Vincent Lavoué, Pierre-Adrien Bolze, Cyrille Huchon, Alexandre Bricou, Geoffroy Canlorbe, Camille Mimoun, Sofiane Bendifallah, Lobna Ouldamer. Lymphovascular space invasion and estrogen receptor status in high-grade serous ovarian cancer – A multicenter study by the FRANCOGYN group. Journal of Gynecology Obstetrics and Human Reproduction 2022; 51(1): 102242 doi: 10.1016/j.jogoh.2021.102242
|